IP Verse

Aragon Pharmaceuticals, Inc. patent opposition analysis

Latest patents of Aragon Pharmaceuticals, Inc. opposed by its competitors

The following table provides an overview of the latest patents of Aragon Pharmaceuticals, Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3226843May 26, 2021Anticancer Compositions1
EP3533792May 5, 2021Crystalline Forms Of An Androgen Receptor Modulator1
EP3226842Nov 25, 2020Anticancer Compositions2
EP3305285Sep 2, 2020Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate Cancer3
EP3348553Jul 8, 2020Crystalline Forms Of An Androgen Receptor Modulator2
EP2945628Apr 15, 2020Androgen Receptor Modulator And Uses Thereof4
EP2858985Apr 18, 2018Crystalline Forms Of An Androgen Receptor Modulator3

Top competitors of Aragon Pharmaceuticals, Inc.